Clifford Swan Investment Counsel’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $31.9M | Sell |
146,672
-1,971
| -1% | -$437K | 1.09% | 25 |
|
|
2025
Q4 | $34M | Sell |
148,643
-3,532
| -2% | -$805K | 1.13% | 22 |
|
|
2025
Q3 | $35.2M | Sell |
152,175
-161
| -0.1% | -$32.8K | 1.17% | 22 |
|
|
2025
Q2 | $28.3M | Sell |
152,336
-1,584
| -1% | -$294K | 1% | 31 |
|
|
2025
Q1 | $32.2M | Sell |
153,920
-2,581
| -2% | -$502K | 1.19% | 21 |
|
|
2024
Q4 | $27.8M | Sell |
156,501
-371
| -0.2% | -$68.2K | 1% | 25 |
|
|
2024
Q3 | $31M | Sell |
156,872
-6,271
| -4% | -$1.17M | 1.1% | 21 |
|
|
2024
Q2 | $28M | Sell |
163,143
-318
| -0.2% | -$52.7K | 1.05% | 24 |
|
|
2024
Q1 | $29.8M | Sell |
163,461
-8,581
| -5% | -$1.48M | 1.11% | 24 |
|
|
2023
Q4 | $26.7M | Sell |
172,042
-1,554
| -0.9% | -$227K | 1.04% | 25 |
|
|
2023
Q3 | $25.9M | Sell |
173,596
-3,593
| -2% | -$527K | 1.09% | 19 |
|
|
2023
Q2 | $23.9M | Sell |
177,189
-1,527
| -0.9% | -$224K | 0.96% | 29 |
|
|
2023
Q1 | $28.5M | Sell |
178,716
-4,172
| -2% | -$638K | 1.19% | 16 |
|
|
2022
Q4 | $29.6M | Sell |
182,888
-6,197
| -3% | -$950K | 1.29% | 15 |
|
|
2022
Q3 | $25.4M | Sell |
189,085
-14,571
| -7% | -$2.09M | 1.19% | 16 |
|
|
2022
Q2 | $31.2M | Buy |
203,656
+62
| +0% | +$9.47K | 1.35% | 14 |
|
|
2022
Q1 | $33M | Sell |
203,594
-6,212
| -3% | -$902K | 1.22% | 15 |
|
|
2021
Q4 | $28.4M | Sell |
209,806
-4,506
| -2% | -$532K | 0.99% | 31 |
|
|
2021
Q3 | $24.6M | Sell |
214,312
-2,687
| -1% | -$307K | 0.9% | 34 |
|
|
2021
Q2 | $25M | Sell |
216,999
-34,559
| -14% | -$3.89M | 0.95% | 32 |
|
|
2021
Q1 | $27.2M | Sell |
251,558
-1,553
| -0.6% | -$166K | 1.12% | 27 |
|
|
2020
Q4 | $27.1M | Sell |
253,111
-5,884
| -2% | -$565K | 1.18% | 25 |
|
|
2020
Q3 | $22.7M | Sell |
258,995
-4,790
| -2% | -$451K | 1.09% | 27 |
|
|
2020
Q2 | $25.9M | Buy |
263,785
+21,430
| +9% | +$1.89M | 1.33% | 14 |
|
|
2020
Q1 | $18.5M | Buy |
242,355
+553
| +0.2% | +$47.1K | 1.12% | 25 |
|
|
2019
Q4 | $21.4M | Buy |
241,802
+11,104
| +5% | +$922K | 1.03% | 30 |
|
|
2019
Q3 | $17.5M | Buy |
230,698
+41,060
| +22% | +$2.82M | 0.91% | 37 |
|
|
2019
Q2 | $13.8M | Buy |
189,638
+5,475
| +3% | +$430K | 0.73% | 46 |
|
|
2019
Q1 | $14.8M | Buy |
184,163
+8,197
| +5% | +$671K | 0.8% | 43 |
|
|
2018
Q4 | $16.2M | Sell |
175,966
-3,343
| -2% | -$294K | 0.98% | 34 |
|
|
2018
Q3 | $17M | Sell |
179,309
-2,320
| -1% | -$220K | 0.88% | 39 |
|
|
2018
Q2 | $16.8M | Sell |
181,629
-525
| -0.3% | -$51.3K | 0.94% | 37 |
|
|
2018
Q1 | $17.2M | Sell |
182,154
-1,542
| -0.8% | -$169K | 0.97% | 35 |
|
|
2017
Q4 | $17.8M | Buy |
183,696
+11,647
| +7% | +$1.1M | 0.97% | 33 |
|
|
2017
Q3 | $15.3M | Sell |
172,049
-6,790
| -4% | -$517K | 0.93% | 34 |
|
|
2017
Q2 | $13M | Sell |
178,839
-8,263
| -4% | -$556K | 0.81% | 42 |
|
|
2017
Q1 | $12.2M | Sell |
187,102
-11,091
| -6% | -$697K | 0.78% | 44 |
|
|
2016
Q4 | $12.4M | Sell |
198,193
-3,491
| -2% | -$213K | 0.83% | 41 |
|
|
2016
Q3 | $12.7M | Sell |
201,684
-1,167
| -0.6% | -$75.5K | 0.86% | 39 |
|
|
2016
Q2 | $12.6M | Sell |
202,851
-7,616
| -4% | -$464K | 0.87% | 38 |
|
|
2016
Q1 | $12M | Sell |
210,467
-1,676
| -0.8% | -$93.4K | 0.82% | 43 |
|
|
2015
Q4 | $12.6M | Sell |
212,143
-2,490
| -1% | -$143K | 0.86% | 40 |
|
|
2015
Q3 | $11.7M | Sell |
214,633
-17,450
| -8% | -$1.14M | 0.84% | 43 |
|
|
2015
Q2 | $15.6M | Sell |
232,083
-4,772
| -2% | -$312K | 1.05% | 34 |
|
|
2015
Q1 | $13.9M | Buy |
236,855
+1,652
| +0.7% | +$99.8K | 0.91% | 39 |
|
|
2014
Q4 | $15.4M | Sell |
235,203
-12,482
| -5% | -$787K | 1.02% | 36 |
|
|
2014
Q3 | $14.3M | Sell |
247,685
-25,167
| -9% | -$1.4M | 0.98% | 34 |
|
|
2014
Q2 | $15.4M | Sell |
272,852
-13,975
| -5% | -$733K | 1.04% | 36 |
|
|
2014
Q1 | $14.7M | Sell |
286,827
-11,463
| -4% | -$579K | 1.03% | 34 |
|
|
2013
Q4 | $15.8M | Sell |
298,290
-9,332
| -3% | -$459K | 1.14% | 32 |
|
|
2013
Q3 | $13.8M | Sell |
307,622
-8,990
| -3% | -$399K | 1.1% | 35 |
|
|
2013
Q2 | $13.1M | Buy |
+316,612
| New | +$13.8M | 1.09% | 34 |
|
Other funds holding ABBV
VCM
VPM
Clifford Swan Investment Counsel's ABBV Position: Q1 2026 in Review
Clifford Swan Investment Counsel reduced its AbbVie (ABBV) stake by 1.3% in Q1 2026, selling an estimated $437K and leaving 146,672 shares worth $31.9M. The position accounts for 1.09% of the portfolio, ranked #25.
Clifford Swan Investment Counsel first reported a position in ABBV in Q2 2013 and has held it in 52 quarters since. The position peaked at $35.2M in Q3 2025. 4,087 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.
- Clifford Swan Investment Counsel held 146,672 shares of AbbVie worth $31.9M as of Q1 2026.
- Clifford Swan Investment Counsel sold 1,971 AbbVie shares in Q1 2026, an estimated $437K.
- AbbVie made up 1.09% of Clifford Swan Investment Counsel's portfolio in Q1 2026, its #25 holding.
- Clifford Swan Investment Counsel first reported a position in AbbVie in Q2 2013 and has held it in 52 quarters since.
- Clifford Swan Investment Counsel's AbbVie position peaked at $35.2M in Q3 2025.
- 4,087 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.
Based on Clifford Swan Investment Counsel's 13F filing for Q1 2026, filed 6 May 2026.